Literature DB >> 14722296

Effects of blocking individual maturation cleavages in murine leukemia virus gag.

Masamichi Oshima1, Delphine Muriaux, Jane Mirro, Kunio Nagashima, Kelly Dryden, Mark Yeager, Alan Rein.   

Abstract

A single protein, termed Gag, is responsible for retrovirus particle assembly. After the assembled virion is released from the cell, Gag is cleaved at several sites by the viral protease (PR). The cleavages catalyzed by PR bring about a wide variety of physical changes in the particle, collectively termed maturation, and convert the particle into an infectious virion. In murine leukemia virus (MLV) maturation, Gag is cleaved at three sites, resulting in formation of the matrix (MA), p12, capsid (CA), and nucleocapsid (NC) proteins. We introduced mutations into MLV that inhibited cleavage at individual sites in Gag. All mutants had lost the intensely staining ring characteristic of immature particles; thus, no single cleavage event is required for this feature of maturation. Mutant virions in which MA was not cleaved from p12 were still infectious, with a specific infectivity only approximately 10-fold below that of the wild type. Particles in which p12 and CA could not be separated from each other were noninfectious and lacked a well-delineated core despite the presence of dense material in their interiors. In both of these mutants, the dimeric viral RNA had undergone the stabilization normally associated with maturation, suggesting that this change may depend upon the separation of CA from NC. Alteration of the C-terminal end of CA blocked CA-NC cleavage but also reduced the efficiency of particle formation and, in some cases, severely disrupted the ability of Gag to assemble into regular structures. This observation highlights the critical role of this region of Gag in assembly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722296      PMCID: PMC321369          DOI: 10.1128/jvi.78.3.1411-1420.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  RNA is a structural element in retrovirus particles.

Authors:  D Muriaux; J Mirro; D Harvin; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.

Authors:  S Tang; T Murakami; B E Agresta; S Campbell; E O Freed; J G Levin
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Reversal by dithiothreitol treatment of the block in murine leukemia virus maturation induced by disulfide cross-linking.

Authors:  Stephen Campbell; Masamichi Oshima; Jane Mirro; Kunio Nagashima; Alan Rein
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.

Authors:  T Fitzon; B Leschonsky; K Bieler; C Paulus; J Schröder; H Wolf; R Wagner
Journal:  Virology       Date:  2000-03-15       Impact factor: 3.616

5.  Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein.

Authors:  Chun Tang; Yasmine Ndassa; Michael F Summers
Journal:  Nat Struct Biol       Date:  2002-07

6.  Murine leukemia virus nucleocapsid mutant particles lacking viral RNA encapsidate ribosomes.

Authors:  Delphine Muriaux; Jane Mirro; Kunio Nagashima; Demetria Harvin; Alan Rein
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.

Authors:  M Shehu-Xhilaga; H G Kraeusslich; S Pettit; R Swanstrom; J Y Lee; J A Marshall; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.

Authors:  S C Pettit; M D Moody; R S Wehbie; A H Kaplan; P V Nantermet; C A Klein; R Swanstrom
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  A structurally disordered region at the C terminus of capsid plays essential roles in multimerization and membrane binding of the gag protein of human immunodeficiency virus type 1.

Authors:  Chen Liang; Jing Hu; James B Whitney; Lawrence Kleiman; Mark A Wainberg
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.

Authors:  J Park; C D Morrow
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

View more
  21 in total

1.  Protein transduction from retroviral Gag precursors.

Authors:  Christine Voelkel; Melanie Galla; Tobias Maetzig; Eva Warlich; Johannes Kuehle; Daniela Zychlinski; Juergen Bode; Tobias Cantz; Axel Schambach; Christopher Baum
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

2.  Effects of Gag mutation and processing on retroviral dimeric RNA maturation.

Authors:  William Fu; Que Dang; Kunio Nagashima; Eric O Freed; Vinay K Pathak; Wei-Shau Hu
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Phosphorylation Requirement of Murine Leukemia Virus p12.

Authors:  Jonathon D Brzezinski; Roland Felkner; Apexa Modi; Mengdan Liu; Monica J Roth
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

4.  Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.

Authors:  Jordan Anderson-Daniels; Parmit K Singh; Gregory A Sowd; Wen Li; Alan N Engelman; Christopher Aiken
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

5.  Role of murine leukemia virus nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Sylvain Costes; Kunio Nagashima; Jane Mirro; Ed Cho; Stephen Lockett; Alan Rein
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Assembly properties of human immunodeficiency virus type 1 Gag-leucine zipper chimeras: implications for retrovirus assembly.

Authors:  Rachael M Crist; Siddhartha A K Datta; Andrew G Stephen; Ferri Soheilian; Jane Mirro; Robert J Fisher; Kunio Nagashima; Alan Rein
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

7.  Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein.

Authors:  Marcy R Auerbach; Kristy R Brown; Ila R Singh
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

8.  Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses.

Authors:  Samuel J Rulli; Jane Mirro; Shawn A Hill; Patricia Lloyd; Robert J Gorelick; John M Coffin; David Derse; Alan Rein
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

9.  Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation.

Authors:  Michael D Moore; William Fu; Ferri Soheilian; Kunio Nagashima; Roger G Ptak; Vinay K Pathak; Wei-Shau Hu
Journal:  Virology       Date:  2008-07-26       Impact factor: 3.616

10.  Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology.

Authors:  Lisa Z Scheifele; Scott P Kenney; Tina M Cairns; Rebecca C Craven; Leslie J Parent
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.